600129.SH
太极集团
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 14.21
−5.71%Margins
Gross margin
31.3%
EBITDA margin
6.2%
EBIT margin
2.2%
Net margin
1.1%
FCF margin
-1.4%
3.1%
Return on equity
0.8%
Return on assets
2.5%
Return on invested capital
0.70x
Asset turnover
CNY 347.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026